Neuropsychopharmacology. 2017 Aug 22. doi: 10.1038/npp.2017.183.
Dubol M1,2, Trichard C1,2,3, Leroy C1,2,4, Sandu AL1,2,5, Rahim M6,7, Granger B1,2,8, Tzavara ET1,2,8,9, Karila L1,2,10, Martinot JL1,2, Artiges E1,2,11.
Abstract
Dopamine function and reward processing are highly interrelated and involve common brain regions afferent to the Nucleus Accumbens, within the mesolimbic pathway. While dopamine function and reward system neural activity are impaired in most psychiatric disorders, it is unknown if alterations in the dopamine system underlie variations in reward processing across a continuum encompassing health and these disorders. We explored the relationship between dopamine function and neural activity during reward anticipation in twenty-seven participants including healthy volunteers and psychiatric patients with schizophrenia, depression or cocaine addiction, using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) multimodal imaging with a voxel-based statistical approach. Dopamine transporter (DAT) availability was assessed with PET and [11C]PE2I as a marker of presynaptic dopamine function, and reward-related neural response was assessed using fMRI with a modified Monetary Incentive Delay task. Across all the participants, DAT availability in the midbrain correlated positively with the neural response to anticipation of reward in the Nucleus Accumbens.
Moreover, this relationship was conserved in each clinical subgroup, despite the heterogeneity of mental illnesses examined. For the first time, a direct link between DAT availability and reward anticipation was detected within the mesolimbic pathway in healthy and psychiatric participants, and suggests that dopaminergic dysfunction is a common mechanism underlying the alterations of reward processing observed in patients across diagnostic categories.
The findings support the use of a dimensional approach in psychiatry, as promoted by the Research Domain Criteria (RDoC) project to identify neurobiological signatures of core dysfunctions underling mental illnesses.Neuropsychopharmacology accepted article preview online, 22 August 2017. doi:10.1038/npp.2017.183.
PMID: 28829051
DOI: 10.1038/npp.2017.183
;